- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02969330
Effect of Peripheral Electrical Stimulation (PES) on Brain Response to Glucose Stimuli
November 17, 2016 updated by: Uri Nevo, Tel Aviv University
Effect of Short Peripheral Electrical Stimulation (PES) on Brain Response to Glucose Stimuli Evaluated by BOLD and Functional Diffusion MRI: a Crossover Pilot Study
The aims of this study are twofold: (1) to develop an innovative approach for studying brain glucose metabolism using functional diffusion weighted imaging (DWI) and BOLD fMRI in humans; (2) to evaluate the effect of short peripheral electrical stimulation (PES) treatment on brain and brain-stem targets, associated with control of food intake and energy expenditure, in response to glucose stimuli, in healthy volunteers.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Uri Nevo, PhD
- Phone Number: 972-3-6407542
- Email: nevouri@post.tau.ac.il
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteers
- Age 18-65 years old.
- Body mass index 18 to 25 kg/m2
- Capable of giving informed consent
Exclusion Criteria:
- Pregnancy, or nursing
- Permanent pacemakers
- Metal prosthesis
- Skin disease
- Claustrophobia
- History of neurological disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Glucose
Glucose ingestion
|
300ml tap water with 75g glucose
|
Active Comparator: PES
Single session of short PES treatment before glucose ingestion.
|
300ml tap water with 75g glucose
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in postprandial cerebral blood flow (fMRI) and cerebral diffusivity (fDWI) in response to glucose ingestion.
Time Frame: changes from baseline to 30 minutes after glucose ingestion
|
changes from baseline to 30 minutes after glucose ingestion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2016
Primary Completion (Anticipated)
January 1, 2018
Study Registration Dates
First Submitted
November 17, 2016
First Submitted That Met QC Criteria
November 17, 2016
First Posted (Estimate)
November 21, 2016
Study Record Updates
Last Update Posted (Estimate)
November 21, 2016
Last Update Submitted That Met QC Criteria
November 17, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 2366-16-SMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Activity
-
Duke UniversityTerminated
-
Massachusetts General HospitalNational Institutes of Health (NIH)CompletedBrain Activity Under SedationUnited States
-
Assistance Publique Hopitaux De MarseilleRecruitingDifference in Regional Brain ActivityFrance
-
University of PennsylvaniaShireCompletedMenopause | Cognition | Brain ActivityUnited States
-
Bruyere Research InstituteCompletedExecutive Function | Motor Activity | Brain StimulationCanada
-
The University of Texas Health Science Center at...Completed
-
Purdue UniversityAmerican Egg BoardCompletedIngestive Behavior | Brain Activity | Appetite | Cholesterol | Glucose ControlUnited States
-
Hacettepe UniversityCompletedEpilepsy | Physical ActivityTurkey
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
Clinical Trials on Glucose
-
University of Texas Southwestern Medical CenterCompletedSarcoma | Neuroblastoma | Pediatric CancerUnited States
-
Children's Mercy Hospital Kansas CityWithdrawnType 1 DiabetesUnited States
-
University of Massachusetts, WorcesterNot yet recruitingPregnancy, High Risk | Type 2 Diabetes Treated With InsulinUnited States
-
Glostrup University Hospital, CopenhagenUnknown
-
Makassed General HospitalCompleted
-
Unilever R&DLeiden University Medical CenterCompleted
-
US Department of Veterans AffairsEmory UniversityCompletedType 2 Diabetes Mellitus | Prediabetic StateUnited States
-
NestléCompletedHealthyNew Zealand